<?xml version="1.0" encoding="UTF-8"?>
<p id="p0135">In a clinical study involving 36 COVID-19 patients, 26 patients received hydroxychloroquine, and ten were taken as control. Six patients among hydroxychloroquine treated groups were given azithromycin to prevent secondary bacterial infections. On the sixth day from the beginning of treatment, all patients undergoing with hydroxychloroquine and azithromycin combination were clinically cured compared to 57.1% of patients treated with hydroxychloroquine alone (
 <xref rid="bib45" ref-type="bibr">Gautret et al., 2020</xref>). This indicated that azithromycin added to hydroxychloroquine was substantially effective for virus removal (
 <xref rid="bib45" ref-type="bibr">Gautret et al., 2020</xref>).
</p>
